BioCardia

Beyond's analysis on BioCardia

• 2026-10-07 — BioCardia’s disclosure of the CardiAMP HF II trial design signals advancement in its heart‑failure therapy pipeline

Recent news mentioning BioCardia

• 2026-10-07 — BioCardia Presents CardiAMP HF II Trial Design at Heart Failure Society of America Annual Scientific Meeting
• 2026-10-01 — BioCardia Files Revised De Novo Pre-Submission for FDA Approval of Helix™ Catheter
• 2026-09-23 — BioCardia Confirms Timing and Provides Update on FDA Helix Pre-Submission and PMDA CardiAMP HF Shonin Submission
• 2026-09-10 — BioCardia to Present CardiAMP Regulatory and Corporate Progress at H.C. Wainwright 28th Annual Global Investment Conference

Appears alongside

• CardiAMP
• FDA
• PMDA

Browse the full archive →